SELUMETINIB

SELUMETINIB (14236G)

selumetinib 10 mg capsule, 60
14236G
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Neurofibromatosis type 1
Treatment phase: Initial treatment

Restriction

Indication: Neurofibromatosis type 1
Treatment phase: Continuing treatment

Restriction

Indication: Neurofibromatosis type 1
Treatment phase: Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 60 # of repeats: 5 DPMQ: $7,112.93 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Koselugo